Herman Cain accused a former consultant to his unsuccessful 2004 Senate campaign, Curt Anderson, of leaking damaging information about past sexual harassment allegations against Cain.
Anderson, who is now an adviser to Rick Perry, denied the charge in an email to POLITICO's Jonathan Martin:?"I?ve known Herman Cain for about 7 years. I was one of several consultants on his Senate race in 2004 and was proud to help him. I'd never heard any of these allegations until I read them in Politico, nor does anything I read in the press change my opinion that Herman is an upstanding man and a gentleman. I have great respect for Herman and his character and I would never speak ill of him, on the record or off the record. That's true today and it's not going to change."
Continue Reading
Cain's inflammatory charge came in an interview with Forbes:
In the summer of 2003, Cain recalls briefing Anderson?his general campaign consultant at the time?that sexual harassment claims were brought against him while he was chairman of the National Restaurant Association from 1996 to 1999.
?I told my wife about this in 1999 and I?ve got nothing to hide,? Cain told me Wednesday. ?When I sat down with my general campaign consultant Kurt Anderson in a private room in our campaign offices in 2003 we discussed opposition research on me. It was a typical campaign conversation. I told him that there was only one case, one set of charges, one woman while I was at the National Restaurant Association. Those charges were baseless, but I thought he needed to know about them. I don?t recall anyone else being in the room when I told him.? ...
Aside from knowing about the alleged sexual harassment accusations, Cain campaign officials point to the timing of Anderson?s hiring by Perry as evidence of his involvement. The campaign announced Anderson?s role on October 24, just a week before Politico broke the story.
Does he regret telling Anderson about it? ?I don?t regret it at all,? Cain says. ?The guy who was supposed to help with strategy should know everything. I put it on the table right from the get go. I wasn?t trying to hide it.?
Related stories:
? Iowa radio host accuses Cain of 'inappropriate' remarks
GM Invests $380 Million in Wentzville Assembly Plant
Plant to become home to new Chevy Colorado, creating or retaining about 1,260 jobs
WENTZVILLE, Mo. ? General Motors will invest approximately $380 million to prepare the Wentzville Assembly plant for production of an all-new Chevrolet Colorado midsize pickup, creating or retaining about 1,260 jobs hourly and salaried jobs.
"The all-new Colorado builds on Chevrolet's strong truck heritage," said Cathy Clegg, GM vice president of Labor Relations. "As we celebrate the first 100 years of Chevrolet today, it is exciting to bring this new global product to the Wentzville team. They also have a strong heritage ? a long-standing commitment to building quality products."
The new Colorado is based on an all-new midsize truck architecture developed by GM do Brasil within GM's global product development organization. In major markets where the Colorado will be sold, including the United States, engineers will tailor the truck to meet local needs.
Wentzville Assembly, which currently has about 1,400 employees, produces the Chevrolet Express and GMC Savana full-size vans. In early October, the plant announced a second shift, adding about 400 employees, to meet customer demand for commercial vans. The second shift will start in January 2012.
"Today's announcement demonstrates that the members of UAW Local 2250 have all the qualities of a world-class work force," said Joe Ashton, UAW vice president representing the GM Department. "We recognize and appreciate their focus on quality, flexibility and hard work. These new products will provide an opportunity for the plant to be more fully utilized and provide good-paying, middle-class jobs for Wentzville. "
The investments will support tooling and equipment upgrades. Product details, timing and pricing will be announced later. The current-generation Colorado will be produced in Shreveport, La., through the 2012 model year.
General Motors Co. (NYSE:GM, TSX: GMM) and its partners produce vehicles in 30 countries, and the company has leadership positions in the world's largest and fastest-growing automotive markets. GM's brands include Chevrolet and Cadillac, as well as Baojun, Buick, GMC, Holden, Isuzu, Jiefang, Opel, Vauxhall and Wuling. More information on the company and its subsidiaries, including OnStar, a global leader in vehicle safety, security and information services, can be found at http://www.gm.com.
Saving for retirement is important, and if you're like most people you may have multiple savings accounts or 401(k) accounts with different banks and investment firms. Personal Capital, is a new web service that wants to bring all of those accounts and investments into one webapp so you can see them in one place and track their performance.
Even if you've taken the time to follow our financial boot camp, you may still have a difficult time keeping track of how your retirement funds are performing and what transaction and maintenance fees are attached to them. Personal Capital wants to make those fees and the performance of your retirement funds and investments more transparent so you're never in doubt about how hard your money is working for you.
In addition to collecting your retirement and investment information into a single view, the service will also suggest changes you can make to help your money perform better, and will analyze your investments to make sure your investment strategy is right for your financial goals, age, and risk tolerance. Personal Capital is still in beta, so keep that in mind if you give it a try, but it could be a great tool to help you cut through the often difficult to understand world of retirement and investment planning.
Personal Capital
You can reach Alan Henry, the author of this post, at alan@lifehacker.com, or better yet, follow him on Twitter or Google+.
Kansas City Chiefs wide receiver Jon Baldwin (89) catches a pass as San Diego Chargers safety Eric Weddle (32) and linebacker Takeo Spikes, right, defend during the first quarter of an NFL football game Monday, Oct. 31, 2011, in Kansas City, Mo. (AP Photo/Jeff Roberson)
Kansas City Chiefs wide receiver Jon Baldwin (89) catches a pass as San Diego Chargers safety Eric Weddle (32) and linebacker Takeo Spikes, right, defend during the first quarter of an NFL football game Monday, Oct. 31, 2011, in Kansas City, Mo. (AP Photo/Jeff Roberson)
Kansas City Chiefs wide receiver Jon Baldwin protects the ball on a 17-yard reception as San Diego Chargers cornerback Marcus Gilchrist, left, and safety Eric Weddle, bottom, defend during the first quarter of an NFL football game Monday, Oct. 31, 2011, in Kansas City, Mo. (AP Photo/Ed Zurga)
KANSAS CITY, Mo. (AP) ? Matt Cassel connected with Jonathan Baldwin for a 39-yard touchdown pass late in the first quarter, giving the Kansas City Chiefs a 10-0 lead over the San Diego Chargers.
Cassel was 5 of 8 for 106 yards in the opening quarter.
He hit Baldwin for 17 yards to convert a long third down on the Chiefs' first drive, and Dwayne Bowe for 26 more on another third-and-long to set up Ryan Succop's 36-yard field goal.
Philip Rivers threw his second interception of the quarter on the Chargers' ensuing drive, turning the momentum back to the Chiefs. Cassel hit fullback Le'Ron McClain for 16 yards, and a personal foul penalty for hitting a defenseless receiver on San Diego moved the ball to the Chargers 39.
Cassel dropped back to pass and saw Baldwin streaking for the end zone. The rookie wide receiver out-jumped fellow rookie Marcus Gilchrist and hauled in his first career touchdown catch.
Rivers continued his early season struggles in the first quarter.
The three-time Pro Bowl quarterback was intercepted by Kendrick Lewis on the first play of San Diego's second possession. His second pick was tipped by defensive lineman Wallace Gilberry and dropped into the hands of Chiefs linebacker Derrick Johnson.
Rivers also threw two fourth-quarter interceptions last week against New York, when the Jets rallied with 17 straight points to stun the AFC West-leading Chargers 27-21. He has thrown seven touchdown passes and 11 interceptions so far this season.
The Chiefs (3-3), who have won three straight after an abysmal start, can move into a tie for first in the division with San Diego (4-2) and the idle Oakland Raiders with a victory before a raucous crowd on Halloween night. They would be the first team in NFL history to lose their first three games and be tied or leading a division after seven games.
With all the Google TV news the past few days, we wanted to let you guys know about Redux. Back at Google I/O Redux was featured by Google as something Google TV was all about -- quality content you can view right in your living room via Google TV. Their HTML 5 app has been in the GTV spotlight (Google's app picks for the Google TV platform) for a while, and to be ready for the Honeycomb rollout, they already have their Android app ready in the Market. That's cool -- Redux is ready for you, but what exactly is Redux? hit the break to find out, and get information where you can check it out right now.
I wish this book, The Table Comes First, didn't have to be a book. I wish it could be a dinner table, instead, with maybe six people sitting around it?not in a jammed-full New York restaurant where everyone is bellowing over the sound system but in somebody's home, where we've all been invited to eat and talk. And I wish Adam Gopnik were at the table, leaning forward intently as the plates come and go, yakking away happily about food and history and Paris and cookbooks and life, just as he does in these pages. Then the rest of us guests could jump in and interrupt him whenever we want, probably knocking over a wine glass in our enthusiasm: "What do you mean, there were no 'big books of recipes' before the 19th century? Hannah Glasse, 1747, indispensable for the next hundred years!" "You don?t really think our current food obsession is the 'father' of the obesity crisis, do you? People are getting fat from eating heirloom tomatoes?poverty and junk food have nothing to do with it?" "Good grief, Adam, listen to your own language?'men' don't invite 'girls' to dinner anymore, and they haven't since about 1972."
The Michael J. Fox Foundation awards nearly $200,000 to develop novel drugs for Parkinson's diseasePublic release date: 31-Oct-2011 [ | E-mail | Share ]
Contact: Mart Saarma mart.saarma@helsinki.fi 358-505-002-726 University of Helsinki
The Michael J. Fox Foundation for Parkinson's Research (MJFF) has awarded a grant to Academy Professor Mart Saarma, PhD, and his team at the Institute of Biotechnology of the University of Helsinki. The funding will be used in conjunction with HermoPharma Company for the therapeutic development of the neurotrophic factor cerebral dopamine neurotrophic factor (CDNF) as a potential treatment for Parkinson's disease (PD).
Saarma's major breakthrough in this field was the discovery of CDNF, and he has performed subsequent demonstrations that it has potential to both protect and repair injured neurons in pre-clinical models of PD. MJFF has been funding Saarma's team to investigate CDNF since 2006, including a $500,000 award in 2010 to study the therapeutic potential of CDNF in pre-clinical models of PD. The newly-awarded grant will be used to further complete these studies.
PD is a disorder of the central nervous system that results from the loss of dopamine-producing brain cells. Neurotrophic factors are are proteins that promote the survival, growth and function of neurons in the brain, and therefore, are of major interest to PD researchers.
Saarma's team and a team headed by Professor Raimo K. Tuominen, MD, PhD, of the Faculty of Pharmacy, have in the past compared the neuroprotective and neurorestorative properties of CDNF with those of other neurotrophic factors like glial cell line-derived neurotrophic factor, or GDNF. The results were promising in terms of developing CDNF as a novel treatment for PD.
Future pre-clinical studies on the efficacy of CDNF on PD are being carried out in collaboration with Judy L. Cameron, PhD, of the University of Pittsburgh and with Zhiming Zhang, MD, of the University of Kentucky.
###
For further information, please contact:
Professor Mart Saarma
Tel. 358 50 500 2726
mart.saarma@helsinki.fi
Laboratory of Molecular Neuroscience at the Institute of Biotechnology:
http://www.biocenter.helsinki.fi/bi/
ABOUT MJFF
As the world's largest private funder of Parkinson's research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson's disease and improved therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program coupled with active global engagement of scientists, Parkinson's patients, business leaders, clinical trial participants, donors and volunteers. In addition to funding more than $264 million in research to date, the Foundation has fundamentally altered the trajectory of progress toward a cure. Operating at the hub of worldwide Parkinson's research, the Foundation forges groundbreaking collaborations with industry leaders, academic scientists and government research funders; increases the flow of participants into Parkinson's disease clinical trials with its online tool, Fox Trial Finder; promotes Parkinson's awareness through high-profile advocacy, events and outreach; and coordinates the grassroots involvement of thousands of Team Fox members around the world. Now through December 31, 2012, all new and increased giving to The Michael J. Fox Foundation, as well as gifts from donors who have not given since 2009 or earlier, will be matched on a dollar-for-dollar basis with the $50-million Brin Wojcicki Challenge, launched by Sergey Brin and Anne Wojcicki.
For more information, visit: www.michaeljfox.org; www.facebook.com/michaeljfoxfoundation
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
The Michael J. Fox Foundation awards nearly $200,000 to develop novel drugs for Parkinson's diseasePublic release date: 31-Oct-2011 [ | E-mail | Share ]
Contact: Mart Saarma mart.saarma@helsinki.fi 358-505-002-726 University of Helsinki
The Michael J. Fox Foundation for Parkinson's Research (MJFF) has awarded a grant to Academy Professor Mart Saarma, PhD, and his team at the Institute of Biotechnology of the University of Helsinki. The funding will be used in conjunction with HermoPharma Company for the therapeutic development of the neurotrophic factor cerebral dopamine neurotrophic factor (CDNF) as a potential treatment for Parkinson's disease (PD).
Saarma's major breakthrough in this field was the discovery of CDNF, and he has performed subsequent demonstrations that it has potential to both protect and repair injured neurons in pre-clinical models of PD. MJFF has been funding Saarma's team to investigate CDNF since 2006, including a $500,000 award in 2010 to study the therapeutic potential of CDNF in pre-clinical models of PD. The newly-awarded grant will be used to further complete these studies.
PD is a disorder of the central nervous system that results from the loss of dopamine-producing brain cells. Neurotrophic factors are are proteins that promote the survival, growth and function of neurons in the brain, and therefore, are of major interest to PD researchers.
Saarma's team and a team headed by Professor Raimo K. Tuominen, MD, PhD, of the Faculty of Pharmacy, have in the past compared the neuroprotective and neurorestorative properties of CDNF with those of other neurotrophic factors like glial cell line-derived neurotrophic factor, or GDNF. The results were promising in terms of developing CDNF as a novel treatment for PD.
Future pre-clinical studies on the efficacy of CDNF on PD are being carried out in collaboration with Judy L. Cameron, PhD, of the University of Pittsburgh and with Zhiming Zhang, MD, of the University of Kentucky.
###
For further information, please contact:
Professor Mart Saarma
Tel. 358 50 500 2726
mart.saarma@helsinki.fi
Laboratory of Molecular Neuroscience at the Institute of Biotechnology:
http://www.biocenter.helsinki.fi/bi/
ABOUT MJFF
As the world's largest private funder of Parkinson's research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson's disease and improved therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program coupled with active global engagement of scientists, Parkinson's patients, business leaders, clinical trial participants, donors and volunteers. In addition to funding more than $264 million in research to date, the Foundation has fundamentally altered the trajectory of progress toward a cure. Operating at the hub of worldwide Parkinson's research, the Foundation forges groundbreaking collaborations with industry leaders, academic scientists and government research funders; increases the flow of participants into Parkinson's disease clinical trials with its online tool, Fox Trial Finder; promotes Parkinson's awareness through high-profile advocacy, events and outreach; and coordinates the grassroots involvement of thousands of Team Fox members around the world. Now through December 31, 2012, all new and increased giving to The Michael J. Fox Foundation, as well as gifts from donors who have not given since 2009 or earlier, will be matched on a dollar-for-dollar basis with the $50-million Brin Wojcicki Challenge, launched by Sergey Brin and Anne Wojcicki.
For more information, visit: www.michaeljfox.org; www.facebook.com/michaeljfoxfoundation
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Saving for retirement is important, and if you're like most people you may have multiple savings accounts or 401(k) accounts with different banks and investment firms. Personal Capital, is a new web service that wants to bring all of those accounts and investments into one webapp so you can see them in one place and track their performance. 
![[ Back to EurekAlert! ]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_u1_mgR_qfSlzZ0H7FrEK608DG18mPNAuXfSRD69-AnWRmJAjhYA48YfiTxJHg-pKp8xll3fuVZDtjADP4ZclkWQqf_6giD8Jp7JARhO2k=s0-d){kind=small}
Public release date: 31-Oct-2011
Share ]